48 related articles for article (PubMed ID: 21093230)
1. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome.
Ahonen TM; Saltevo JT; Kautiainen HJ; Kumpusalo EA; Vanhala MJ
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):285-91. PubMed ID: 21093230
[TBL] [Abstract][Full Text] [Related]
2. Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure.
Ahonen T; Saltevo J; Laakso M; Kautiainen H; Kumpusalo E; Vanhala M
Mediators Inflamm; 2009; 2009():959281. PubMed ID: 19707530
[TBL] [Abstract][Full Text] [Related]
3. The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome.
Tabak O; Simsek G; Erdenen F; Sozer V; Hasoglu T; Gelisgen R; Altunoglu E; Muderrisoglu C; Senyigit A; Uzun H
Arch Endocrinol Metab; 2017 Dec; 61(6):515-523. PubMed ID: 28977161
[TBL] [Abstract][Full Text] [Related]
4. Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.
Kaas A; Pfleger C; Hansen L; Buschard K; Schloot NC; Roep BO; Mortensen HB;
Clin Exp Immunol; 2010 Sep; 161(3):444-52. PubMed ID: 20529086
[TBL] [Abstract][Full Text] [Related]
5. Whey and Casein Proteins and Medium-Chain Saturated Fatty Acids from Milk Do Not Increase Low-Grade Inflammation in Abdominally Obese Adults.
Bohl M; Bjørnshave A; Gregersen S; Hermansen K
Rev Diabet Stud; 2016; 13(2-3):148-157. PubMed ID: 28012280
[TBL] [Abstract][Full Text] [Related]
6. Differential Associations of Inflammatory Markers With Insulin Sensitivity and Secretion: The Prospective METSIM Study.
Fizelova M; Jauhiainen R; Kangas AJ; Soininen P; Ala-Korpela M; Kuusisto J; Laakso M; Stancáková A
J Clin Endocrinol Metab; 2017 Sep; 102(9):3600-3609. PubMed ID: 28911155
[TBL] [Abstract][Full Text] [Related]
7. Long-term variability of inflammatory markers and associated factors in a population-based cohort.
Nash SD; Cruickshanks KJ; Klein R; Klein BE; Nieto FJ; Chappell R; Schubert CR; Tsai MY
J Am Geriatr Soc; 2013 Aug; 61(8):1269-76. PubMed ID: 23889670
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific role and associated downstream signaling pathways of adiponectin.
Roy B; Palaniyandi SS
Cell Biosci; 2021 Apr; 11(1):77. PubMed ID: 33902691
[TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Oxidative Stress, Selenium, and Cumulative Risk in Metabolic Syndrome.
Danciu AM; Ghitea TC; Bungau AF; Vesa CM
In Vivo; 2023; 37(6):2877-2887. PubMed ID: 37905638
[TBL] [Abstract][Full Text] [Related]
10. Association of baseline and changes in adiponectin, homocysteine, high-sensitivity C-reactive protein, interleukin-6, and interleukin-10 levels and metabolic syndrome incidence: Tehran lipid and glucose study.
Zahedi AS; Daneshpour MS; Akbarzadeh M; Hedayati M; Azizi F; Zarkesh M
Heliyon; 2023 Sep; 9(9):e19911. PubMed ID: 37809533
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Oxidative Stress in Metabolic Syndrome.
Masenga SK; Kabwe LS; Chakulya M; Kirabo A
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175603
[TBL] [Abstract][Full Text] [Related]
12. Useful Biomarkers of Metabolic Syndrome.
Cho Y; Lee SY
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429722
[TBL] [Abstract][Full Text] [Related]
13. Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review.
Pluimakers VG; van Santen SS; Fiocco M; Bakker ME; van der Lelij AJ; van den Heuvel-Eibrink MM; Neggers SJCMM
Obes Rev; 2021 Nov; 22(11):e13312. PubMed ID: 34258851
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Acceptance and Commitment Therapy (ACT) Intervention on Inflammation and Stress Biomarkers: a Randomized Controlled Trial.
Järvelä-Reijonen E; Puttonen S; Karhunen L; Sairanen E; Laitinen J; Kolehmainen M; Pihlajamäki J; Kujala UM; Korpela R; Ermes M; Lappalainen R; Kolehmainen M
Int J Behav Med; 2020 Oct; 27(5):539-555. PubMed ID: 32394219
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin inhibits NLRP3 inflammasome by modulating the AMPK-ROS pathway.
Wang F; Liu Y; Yang W; Yuan J; Mo Z
Int J Clin Exp Pathol; 2018; 11(7):3338-3347. PubMed ID: 31949710
[TBL] [Abstract][Full Text] [Related]
16. Serum IL-1 Receptor Antagonist Concentrations Associate With Unfavorable Metabolic Features in 12-Year-Old Children.
Seppä S; Tenhola S; Voutilainen R
J Endocr Soc; 2018 Aug; 2(8):870-881. PubMed ID: 30094409
[TBL] [Abstract][Full Text] [Related]
17. Plasma IL-1 Receptor Antagonist Concentration Has an Inverse Association With Birth Weight in Prepubertal Children.
Nordman H; Voutilainen R; Antikainen L; Jääskeläinen J
J Endocr Soc; 2018 Mar; 2(3):232-239. PubMed ID: 29594257
[TBL] [Abstract][Full Text] [Related]
18. miR-758-3p: a blood-based biomarker that's influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome.
O'Neill S; Larsen MB; Gregersen S; Hermansen K; O'Driscoll L
Oncotarget; 2018 Feb; 9(10):9379-9390. PubMed ID: 29507696
[TBL] [Abstract][Full Text] [Related]
19. Visceral Fat Area and Serum Adiponectin Level Predict the Development of Metabolic Syndrome in a Community-Based Asymptomatic Population.
Cho SA; Joo HJ; Cho JY; Lee SH; Park JH; Hong SJ; Yu CW; Lim DS
PLoS One; 2017; 12(1):e0169289. PubMed ID: 28046037
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
